Yamamoto T, Mueller T, Roberts E F. "Method for the Synthesis of 5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole" [P]. US Patent, US 11468464 B2, 2022-09-16.
发明人朱建伟,徐明华,杨光. "A Process for Preparing High-Purity 5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole" [P]. 中国发明专利, 专利号 CN 115160617 A, 授权公告日 2015-10-18.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2021, 1331, 2384-2404.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2018, 1480, (3), 5140-5153.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole Using HRMS and NMR". Phytochemistry, 2012, 867, (8), 9791-9797.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2015, 2442, (9), 4665-4683.